Eurasian Journal of Medical and Natural Sciences 2-jild 5-son (2022) · 211–219-betlar

CLINICAL AND HEMODYNAMIC CONDITIONS AND HEART NATRIURETIC PEPTIDES IN THE BLOOD PLASMA OF PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY

Madjidova, G.T., Sunnatova, G.I., Hamidov, N.S.

DOI: 10.5281/zenodo.6590298 · Manbada o'qish →

Annotatsiya

Hypertrophic cardiomyopathy (GKM), according to the current classification [1], is classified as primary cardiomyopathies, primarily a genetically determined disease of the heart muscle characterized by a complex set of specific morphofunctional changes and a steadily worsening course. The symptoms of the disease are varied and vague and are associated with hemodynamic disturbances - diastolic dysfunction against the background of massive hypertrophy of the left (CH Q) and or right ventricular myocardium, often asymmetric due to thickening of the interventricular septum (IVS), left ventricle (CH Q) with frequent development of outflow tract obstruction, myocardial ischemia, pathology of autonomic circulation regulation and disruption of electrophysiological processes in the heart

hypertrophic cardiomyopathynatriuretic peptides,diastolic function.

Metadata manbasi: jurnal OAI-PMH arxivi · Sindex to'liq matnni saqlamaydi, manbaga havola beradi.